CELLECTAR BIOSCIENCES INC's ticker is CLRB and the CUSIP is 15117F500. A total of 33 filers reported holding CELLECTAR BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $39,000 | -40.9% | 95,438 | 0.0% | 0.00% | – |
| Q1 2022 | $66,000 | +4.8% | 95,438 | 0.0% | 0.00% | – |
| Q4 2021 | $63,000 | -28.4% | 95,438 | 0.0% | 0.00% | – |
| Q3 2021 | $88,000 | -22.8% | 95,438 | 0.0% | 0.00% | – |
| Q2 2021 | $114,000 | -26.0% | 95,438 | 0.0% | 0.00% | – |
| Q1 2021 | $154,000 | +67.4% | 95,438 | +114.8% | 0.00% | – |
| Q4 2020 | $92,000 | +196.8% | 44,424 | +77.1% | 0.00% | – |
| Q3 2020 | $31,000 | – | 25,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 193,510 | $230,276,000 | 0.72% |
| Consonance Capital Management LP | 3,913,000 | $4,656,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 217,500 | $259,000 | 0.13% |
| FNY Investment Advisers, LLC | 220,321 | $262,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 426,561 | $508,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 297,653 | $354,000 | 0.04% |
| Boxer Capital, LLC | 920,000 | $1,095,000 | 0.04% |
| Maven Securities LTD | 650,000 | $793,000 | 0.03% |
| Sterneck Capital Management, LLC | 30,000 | $34,000 | 0.02% |
| 1900 WEALTH MANAGEMENT LLC | 60,000 | $71,000 | 0.01% |